These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 25883388

  • 1. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads.
    Metcalf Pate KA, Pohlmeyer CW, Walker-Sperling VE, Foote JB, Najarro KM, Cryer CG, Salgado M, Gama L, Engle EL, Shirk EN, Queen SE, Chioma S, Vermillion MS, Bullock B, Li M, Lyons CE, Adams RJ, Zink MC, Clements JE, Mankowski JL, Blankson JN.
    J Infect Dis; 2015 Nov 01; 212(9):1387-96. PubMed ID: 25883388
    [Abstract] [Full Text] [Related]

  • 2. A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.
    Charlins P, Schmitt K, Remling-Mulder L, Hogan LE, Hanhauser E, Hobbs KS, Hecht F, Deeks SG, Henrich TJ, Akkina R.
    Virology; 2017 Jul 01; 507():135-139. PubMed ID: 28432928
    [Abstract] [Full Text] [Related]

  • 3. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
    Kim KC, Choi BS, Kim KC, Park KH, Lee HJ, Cho YK, Kim SI, Kim SS, Oh YK, Kim YB.
    AIDS Res Hum Retroviruses; 2016 Feb 01; 32(2):194-202. PubMed ID: 26564392
    [Abstract] [Full Text] [Related]

  • 4. Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques.
    Avalos CR, Price SL, Forsyth ER, Pin JN, Shirk EN, Bullock BT, Queen SE, Li M, Gellerup D, O'Connor SL, Zink MC, Mankowski JL, Gama L, Clements JE.
    J Virol; 2016 Jun 15; 90(12):5643-5656. PubMed ID: 27030272
    [Abstract] [Full Text] [Related]

  • 5. The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs.
    Metcalf Pate KA, Blankson JN.
    Retrovirology; 2017 Nov 21; 14(1):52. PubMed ID: 29157283
    [Abstract] [Full Text] [Related]

  • 6. Establishment of a Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs.
    Flerin NC, Bardhi A, Zheng JH, Korom M, Folkvord J, Kovacs C, Benko E, Truong R, Mota T, Connick E, Jones RB, Lynch RM, Goldstein H.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30626677
    [Abstract] [Full Text] [Related]

  • 7. A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy.
    Araínga M, Edagwa B, Mosley RL, Poluektova LY, Gorantla S, Gendelman HE.
    Retrovirology; 2017 Mar 09; 14(1):17. PubMed ID: 28279181
    [Abstract] [Full Text] [Related]

  • 8. Ultra-Sensitive HIV-1 Latency Viral Outgrowth Assays Using Humanized Mice.
    Schmitt K, Akkina R.
    Front Immunol; 2018 Mar 09; 9():344. PubMed ID: 29556230
    [Abstract] [Full Text] [Related]

  • 9. Amplification of Replication Competent HIV-1 by Adoptive Transfer of Human Cells From Infected Humanized Mice.
    Su H, Sravanam S, Gorantla S, Kaminski R, Khalili K, Poluektova L, Gendelman HE, Dash PK.
    Front Cell Infect Microbiol; 2020 Mar 09; 10():38. PubMed ID: 32117811
    [Abstract] [Full Text] [Related]

  • 10. Molecular methods for evaluation of virological status of nonhuman primates challenged with simian immunodeficiency or simian-human immunodeficiency viruses.
    Lee EM, Chung HK, Livesay J, Suschak J, Finke L, Hudacik L, Galmin L, Bowen B, Markham P, Cristillo A, Pal R.
    J Virol Methods; 2010 Feb 09; 163(2):287-94. PubMed ID: 19878696
    [Abstract] [Full Text] [Related]

  • 11. Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.
    Bruel T, Hamimi C, Dereuddre-Bosquet N, Cosma A, Shin SY, Corneau A, Versmisse P, Karlsson I, Malleret B, Targat B, Barré-Sinoussi F, Le Grand R, Pancino G, Sáez-Cirión A, Vaslin B.
    J Virol; 2015 Apr 09; 89(7):3542-56. PubMed ID: 25589645
    [Abstract] [Full Text] [Related]

  • 12. A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.
    Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C, Macken C, Richman DD, Christopherson C, June CH, Lazar R, Broad DF, Jalali S, Hege KM.
    Mol Ther; 2002 Jun 09; 5(6):788-97. PubMed ID: 12027564
    [Abstract] [Full Text] [Related]

  • 13. Measuring the Inducible, Replication-Competent HIV Reservoir Using an Ultra-Sensitive p24 Readout, the Digital ELISA Viral Outgrowth Assay.
    Stuelke EL, James KS, Kirchherr JL, Allard B, Baker C, Kuruc JD, Gay CL, Margolis DM, Archin NM.
    Front Immunol; 2020 Jun 09; 11():1971. PubMed ID: 32849659
    [Abstract] [Full Text] [Related]

  • 14. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.
    Otero M, Nunnari G, Leto D, Sullivan J, Wang FX, Frank I, Xu Y, Patel C, Dornadula G, Kulkosky J, Pomerantz RJ.
    AIDS Res Hum Retroviruses; 2003 Dec 09; 19(12):1097-103. PubMed ID: 14709246
    [Abstract] [Full Text] [Related]

  • 15. Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.
    Walker-Sperling VE, Buckheit RW, Blankson JN.
    J Virol; 2014 Sep 01; 88(17):9789-98. PubMed ID: 24942573
    [Abstract] [Full Text] [Related]

  • 16. Suppression of Active HIV-1 Infection in CD34+ Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs.
    Latinovic OS, Neal LM, Tagaya Y, Heredia A, Medina-Moreno S, Zapata JC, Reitz M, Bryant J, Redfield RR.
    AIDS Res Hum Retroviruses; 2019 Aug 01; 35(8):718-728. PubMed ID: 31099257
    [Abstract] [Full Text] [Related]

  • 17. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.
    Eriksson S, Graf EH, Dahl V, Strain MC, Yukl SA, Lysenko ES, Bosch RJ, Lai J, Chioma S, Emad F, Abdel-Mohsen M, Hoh R, Hecht F, Hunt P, Somsouk M, Wong J, Johnston R, Siliciano RF, Richman DD, O'Doherty U, Palmer S, Deeks SG, Siliciano JD.
    PLoS Pathog; 2013 Feb 01; 9(2):e1003174. PubMed ID: 23459007
    [Abstract] [Full Text] [Related]

  • 18. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.
    Goujard C, Girault I, Rouzioux C, Lécuroux C, Deveau C, Chaix ML, Jacomet C, Talamali A, Delfraissy JF, Venet A, Meyer L, Sinet M, ANRS CO6 PRIMO Study Group.
    Antivir Ther; 2012 Feb 01; 17(6):1001-9. PubMed ID: 22865544
    [Abstract] [Full Text] [Related]

  • 19. Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy.
    Shiu C, Cunningham CK, Greenough T, Muresan P, Sanchez-Merino V, Carey V, Jackson JB, Ziemniak C, Fox L, Belzer M, Ray SC, Luzuriaga K, Persaud D, Pediatric AIDS Clinical Trials Group P1059 Team.
    J Virol; 2009 Oct 01; 83(19):9731-42. PubMed ID: 19605490
    [Abstract] [Full Text] [Related]

  • 20. Improved assays to measure and characterize the inducible HIV reservoir.
    Massanella M, Yek C, Lada SM, Nakazawa M, Shefa N, Huang K, Richman DD.
    EBioMedicine; 2018 Oct 01; 36():113-121. PubMed ID: 30316868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.